J&J and ChemImage Settle Dispute After $77M AI Patent Verdict

Johnson & Johnson has reached an agreement to resolve a lawsuit with ChemImage Corp. following a $76.6 million judgment in favor of ChemImage. The lawsuit alleged that J&J unilaterally terminated a deal to develop artificial intelligence imaging techniques for surgeries. The resolution comes after a New York federal judge ruled in favor of ChemImage in the dispute. The legal battle between the two companies has now come to an end with this settlement agreement. The terms of the settlement were not disclosed publicly. The lawsuit was a significant one, with ChemImage accusing Johnson & Johnson of breaching their agreement to collaborate on the development of innovative in-surgery AI imaging technologies. The dispute escalated to the point where the court intervened, ultimately awarding ChemImage $76.6 million in damages. Both Johnson & Johnson and ChemImage have expressed their satisfaction with the resolution of the dispute and are looking forward to moving past this legal conflict. For more information on this case and other legal news, subscribe to Law360 for comprehensive coverage and analysis of the latest legal developments.